DEFA14A: NorthStar Healthcare Supplements Merger Proxy Amid Shareholder Lawsuits, Details Go-Shop Process and Financial Projections

NorthStar Healthcare Income, Inc. has filed a supplemental proxy statement to address shareholder lawsuits challenging disclosures related to its pending merger with an affiliate of Welltower, providing additional details on the merger process and financial forecasts.

Summary

• NorthStar Healthcare Income, Inc. (NorthStar Healthcare) filed a DEFA14A to supplement its Definitive Proxy Statement concerning the merger with Compound Holdco LLC, an affiliate of Welltower OP LLC.
• The merger agreement was initially entered into on January 29, 2025, with a special meeting of stockholders scheduled for June 4, 2025, at 10:00 a.m. Eastern Time to vote on the transaction.
• Six Stockholder Actions, comprising four demand letters and two complaints, have been initiated by purported Company stockholders, alleging inadequate disclosures in the preliminary and definitive proxy statements.
• The Company denies the allegations, asserting that no supplemental disclosure was legally required, but is providing additional information voluntarily to mitigate potential litigation burden, moot disclosure claims, and avoid delays to the merger.
• Supplemental disclosures include details on the marketing process, noting 21 initial confidentiality agreements, 22 parties contacted during the go-shop period (12 affirmed interest), and an additional 15 parties approached (5 expressed interest), with no third-party acquisition proposals received during the go-shop period.
• Welltower's initial non-binding offer on November 15, 2024, was for $3.03 per share, representing an equity value of approximately $563 million and a gross asset value of approximately $935 million, and was not subject to a financing condition.
• Discussions regarding post-closing employment for NorthStar Healthcare management, including Mr. Young, occurred after the go-shop period, but no agreement was reached, and no management members are expected to be employed by the acquiring entities.
• The document provides updated financial advisor opinion details, including a peer group market valuation and parameters for the discounted cash flow analysis, utilizing discount rates from 10.0% to 13.5% and entity cap rates from 6.0% to 7.0%, yielding an illustrative undiscounted terminal value of $1,131.2 million.
• Unaudited prospective financial data for fiscal years 2024-2029 has been updated, showing projected NOI (at NHI Share) increasing from $63.9 million in 2024 to $84.3 million in 2029, and EBITDA (at NHI Share) rising from $51.5 million in 2024 to $71.4 million in 2029.

Sentiment

Score: 5

Explanation: The document is largely neutral, serving as a procedural update to a previously announced merger. While it addresses negative elements (stockholder lawsuits), the company maintains its stance that the allegations are without merit and is proceeding with the merger, indicating a commitment to the transaction despite the legal challenges. The supplemental disclosures aim to mitigate risks rather than signal new positive or negative operational developments.

Positives

• The Company believes the allegations in the Stockholder Actions are without merit and denies any legal necessity for supplemental disclosures.
• Welltower's acquisition proposal was not subject to a financing condition, indicating a firm commitment.
• Welltower was open to a 'go-shop' period, allowing NorthStar Healthcare to solicit competing bids, demonstrating a degree of flexibility in the acquisition process.

Negatives

• Six Stockholder Actions (four demand letters and two complaints) have been filed against the Company, challenging the adequacy of merger disclosures.
• The two complaints, Sullivan v. NorthStar Healthcare Income, Inc., et al., Index No. 652792/2025 and Prince v. NorthStar Healthcare Income, Inc., et al., Index No. 652795/2025, were filed in the Supreme Court of the State of New York, County of New York.
• The Company is incurring the burden and expense of potential litigation, despite believing the allegations are without merit.
• The Stockholder Actions pose a potential risk of delay or disruption to the Merger.

Risks

• The occurrence of any event, change, or other circumstances that could lead to the termination of the Merger Agreement.
• The nature, cost, and outcome of any litigation and other legal proceedings, including those related to the Merger, that may be instituted against the parties.
• The inability to consummate the Merger within the anticipated timeframe, or at all, due to factors such as failure to obtain requisite stockholder approval, regulatory approvals, or other conditions.
• Risks that the proposed Merger could disrupt NorthStar Healthcare's current plans and operations or divert management's attention from ongoing business activities.
• The ability to recognize the anticipated benefits of the Merger may not be achieved.
• The amount of costs, fees, expenses, and charges associated with the Merger could be higher than anticipated.
• The risk that the merger agreement may be terminated under circumstances requiring NorthStar Healthcare to pay a termination fee.
• The potential effect of the Merger announcement on NorthStar Healthcare's ability to retain and hire key personnel and maintain relationships with its managers, residents, and business partners.
• The potential effect of the Merger announcement on NorthStar Healthcare's operating results and business generally.
• Other risks and important factors identified in NorthStar Healthcare's filings with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and subsequent reports.

Future Outlook

The document provides prospective financial data for NorthStar Healthcare through 2029, projecting growth in Net Operating Income (NOI), EBITDA, and Unlevered Cash Flow. The primary forward-looking event is the consummation of the merger with Welltower, subject to stockholder approval and other closing conditions, with the special meeting scheduled for June 4, 2025.

Management Comments

• "The Company believes that the allegations in the Stockholder Actions are without merit."
• "The Company denies all allegations in the Stockholder Actions, and believes no supplemental disclosure to the Definitive Proxy Statement was or is required under any applicable law, rule or regulation."
• "However, solely to eliminate the burden and expense of potential litigation, to moot certain of plaintiffs disclosure claims, to avoid potential delay or disruption to the Merger, and to provide additional information to the Company’s stockholders, the Company has determined to voluntarily supplement the Definitive Proxy Statement with the below disclosures."
• "The Company believes that the disclosures set forth in the Definitive Proxy Statement comply fully with applicable law and nothing in the below supplemental disclosure will be deemed an admission of the legal necessity or materiality under applicable law of any of the disclosures set forth herein."
• "It is expected that no members of NorthStar Healthcare management will be employed by Merger Sub or any other affiliates of Welltower after closing."

Industry Context

NorthStar Healthcare operates within the healthcare real estate investment trust (REIT) sector, as evidenced by the types of parties contacted during the marketing process (REITs, healthcare providers, operators) and the peer group used for valuation analysis (Sabra Health Care REIT, American Healthcare REIT, CareTrust REIT, National Health Investors Inc., LTC Properties Inc.). The proposed acquisition by Welltower, a major player in healthcare real estate, signifies ongoing consolidation and strategic M&A activity within the sector.

Comparison to Industry Standards

• The document provides a peer group market valuation as of January 24, 2025, for comparison:
• Sabra Health Care REIT, Inc.: Share Price $16.92, Equity Market Value $4,003.0 million, Total Enterprise Value $6,410.3 million.
• American Healthcare REIT, Inc.: Share Price $28.90, Equity Market Value $4,423.5 million, Total Enterprise Value $6,284.2 million.
• CareTrust REIT, Inc.: Share Price $26.91, Equity Market Value $4,613.7 million, Total Enterprise Value $5,077.9 million.
• National Health Investors Inc.: Share Price $69.62, Equity Market Value $3,162.3 million, Total Enterprise Value $4,301.5 million.
• LTC Properties Inc.: Share Price $34.38, Equity Market Value $1,495.2 million, Total Enterprise Value $2,339.1 million.
• NorthStar Healthcare's proposed equity value of approximately $563 million is significantly lower than all listed peers, suggesting it is a smaller entity within the healthcare REIT space or is being acquired at a valuation that reflects its specific asset portfolio and market position relative to these larger, publicly traded comparables.

Legal Proceedings

• Four demand letters have been sent on behalf of purported Company stockholders challenging the adequacy of certain disclosures in the Preliminary and Definitive Proxy Statements.
• Two complaints have been filed on behalf of purported Company stockholders in the Supreme Court of the State of New York, County of New York.
• The complaints are captioned Sullivan v. NorthStar Healthcare Income, Inc., et al., Index No. 652792/2025 and Prince v. NorthStar Healthcare Income, Inc., et al., Index No. 652795/2025.
• The Company believes the allegations in these Stockholder Actions are without merit and denies any legal necessity for supplemental disclosure.

Stakeholder Impact

• Shareholders: Are being asked to vote on the merger and are receiving supplemental disclosures to address concerns raised by other shareholders through litigation. The outcome of the merger vote and the litigation could directly impact their investment.
• Management: Discussions occurred regarding potential post-closing employment for Mr. Young and other management, but it is expected that no NorthStar Healthcare management will be employed by the acquiring entities after closing, indicating a change in their employment status.
• Creditors: The merger and associated financial restructuring could impact existing debt agreements and credit relationships, though specific details are not provided in this supplement.

Next Steps

• NorthStar Healthcare stockholders will hold a Special Meeting on June 4, 2025, at 10:00 a.m. Eastern Time to vote on the proposed Merger and related transactions.
• Consummation of the Merger, subject to stockholder approval and satisfaction of other terms and conditions set forth in the Merger Agreement.

Key Dates

Keywords

NorthStar Healthcare Income, Welltower, Merger, SEC Filing, Proxy Statement, Stockholder Lawsuit, Healthcare REIT, Corporate Governance, Financial Disclosure, Acquisition, Real Estate, Special Meeting, DEFA14A